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1. Introduction 
With rapidly ageing populations, dementia caused by neurodegenerative diseases has 
become a global socioeconomic issue. Globally, more than 24 million people were 
suffering from dementia in 2005 (C. Ferri et al.,2005). Alzheimer’s disease (AD) is the most 
common cause of dementia. While characterized by the presence of Amyloid-beta () 
peptide plaques in the brain (Masters and Beyreuther, 2006), a major source of the 
neurotoxicity in AD is now believed to be due to the action of soluble  oligomers 
(Crouch et al., 2008).  is generated from the amyloid precursor protein (APP) by the 
action of - and - secretases, and yields peptides 39-43 amino acid residues long, with 
(1-40) and (1-42) the most common. (1-42) has the primary sequence 
D1AEFRH6DSGY10E11VH13H14QK16LVFFAEDVGSNK28GAIIGLM35VGGVVIA42). Structural 
characterization of the formation of the  oligomers is currently the subject of intensive 
research. Among the possible mechanisms are those mediated by the interaction of  with 
metal ions. This includes both redox-active metals such as Copper, and Iron, as well as 
redox-inactive metals such as Zinc. For example, interaction of Cu(II) (i.e. Cu2+) with  in 
the presence of reducing agents leads to the production of reactive oxygen species (ROS). 
This in turn can generate toxic soluble  oligomers via the formation of di-tyrosine cross-
linked  dimers (Barnham et al., 2004). The Copper-chelating compound PBT2 has shown 
efficacy and safety in Phase IIa clinical trials (Adlard et al., 2008). More recently, Platinum 
and Ruthenium compounds have been synthesized and shown to ablate -mediated 
neurotoxicity. Clearly, interaction of metals with  plays an important role in the aetiology 
of AD and is very relevant to the design of effective therapeutics. Knowledge of the atomic 
structure of metals bound to the  peptide would greatly facilitate the design of such 
chemical entities and assist in the elucidation of the mechanisms of neurotoxicity.  
This chapter will review important recent developments in determination of the structure of 
 bound to transition metals (in different oxidation states) and organometallic compounds. 
While X-ray crystallography has so far been unsuccessful in determining the structure of 
any metal- complexes, methods such as NMR (nuclear magnetic resonance), EPR 
(electron paramagnetic resonance), and XAS (X-ray Absorption Spectroscopy) have been 
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used, with varying degrees of success, in the structural determinations of metal binding sites 
and interactions of . These experiments have been carried out on human and rat or 
murine , mutants of , and on constructs of different lengths, for example 1-16, 1-40, 
and 1-42. In a number of instances, these experiments have been supplemented by 
computational studies, usually ab initio quantum mechanical calculations. Computational 
simulations have also been instrumental in shedding light on how redox-active metals may 
initiate mechanisms of toxicity via binding to . This review will also discuss how recent 
computational studies have helped in the elucidation of metal interactions of  and the 
interplay between theory/computation and experiment in furthering our understanding of 
the atomic structures of metal- complexes. The following sections of this chapter will 
consider, in turn, the interactions of amyloid beta with the transition metals copper, iron, 
and zinc. This will be followed by a section of the interaction of  with organometallic 
compounds containing Pt, Ru, Rh, and Ir, before concluding the chapter. 
2. Copper and amyloid beta 
Copper interaction with amyloid-beta has been the subject of more experimental and 
computational investigations than any other metal. This is not only because plaques in AD 
brains are significantly enriched in copper, and Cu(II) binding facilitates aggregation of 
in vitro (Atwood et al., 1998), but also because as a very redox-active metal it plays a 
direct role in the generation of toxic reactive oxygen species (ROS).  
Cu(II) concentration in the synaptic cleft can reach as much as 15 μM following post-
synaptic release (Duce and Bush, 2010). Lovell et al. (1998) found that senile plaques in AD 
brains are enriched in copper almost five times compared with normal neuropils. AD brains 
also typically exhibit signs of oxidative stress such as enhanced levels of dityrosine species, 
4-hydroxy nonenal, 8-hydroxy guanosine, protein carbonyl, and lipid peroxidation species 
(Sayre et al., 1997, Hensley et al., 1998). Cu(II) bound to can, in the presence of reducing 
agents such as ascorbate and glutathione, abundant in the brain, activate and reduce 
molecular O2 to produce H2O2. During this redox cycle, Cu(II) bound to first gets 
reduced to Cu(I) by the reducing agent, and then gets oxidized back to Cu(II). This H2O2 
produced can then lead to a cascade of ROS being generated through Fenton-like and 
Haber-Weiss chemistry (Smith et al., 2007). Attack by these very reactive free radicals on 
proteins, nucleic acids, and lipids would lead to the formation of the oxidatively modified 
products isolated from AD brain tissue. The amyloid beta peptide is itself modified by the 
ROS, leading for example, hydroxylation of the histidine side-chains and the oxidation of 
the methionine side-chain (Nadal et al. 2008). The most important modification of may 
be at the Tyrosine 10 position. The tyrosyl radicals produced may combine, leading to 
covalently cross-linked dimers. Barnham et al. (2004) showed that the Y10A mutant of 
was not toxic in neuronal cell assays. This was the case despite Y10A mutant producing 
H2O2 at half the rate of that by the wild-type peptide. Cappai and Barnham (2008) proposed 
that the covalently cross-linked oligomers produced by this Cu(II) catalyzed redox 
process is the genesis of -induced neurotoxicity. Hence, it is possible that the 
Cu(II)/redox chemistry initiates the generation of toxic soluble oligomers (which are 
toxic by mechanisms as of yet undetermined) rather than the neurodegeneration in AD 
being directly the result of the ROS generation.  
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Early reports (Huang et al., 1999a, 1999b) of Cu(II)/generation of H2O2 appeared to 
indicate that this process could occur in the absence of any external reducing agents, 
presumably via the involvement of Met 35 residue of the peptide itself. They also reported a 
rather high reduction potential (E0) of +0.74-0.79 V versus the Normal Hydrogen Electrode 
(NHE) for the Cu(II)/system. However, later cyclic voltammetry experiments by Jiang et 
al. (2007) established this value to be +0.28 V. The latter also point out that the measured 
oxidation potential value for Met 35 makes it unlikely to act as a reductant in vitro. 
Likewise, the standard reduction potential values of 0.370 V, 0.372 V, and 0.384 V vs. NHE 
for dopamine, epinephrine, and norepinephrine, respectively, render them incapable of 
acting as external reducing agents in the generation of H2O2 by Cu(II)/. X-ray Absorption 
spectroscopy (XAS) studies performed on the Cu(II)/(1-16)/dopamine system by 
Streltsov and Varghese (2008) confirmed this when they did not observe the characteristic 
Cu(I) XANES (X-ray Absorption Near Edge Spectroscopy) spectra. On the other hand, the 
reduction potential for ascorbic acid, 0.051-0.058 V vs. NHE allows the oxidation of 
ascorbate by Cu(II)/to bethermodynamically favourable. Finally, Nadal et al. (2008) 
observed that the Cu(II)//Ascorbate system generated the same amount of H2O2 as 
Cu(II) /Ascorbate (in the absence of ) and inferred that acts as an antioxidant or free 
radical scavenger by quenching the hydroxyl ions produced by Cu(II)/Ascorbate. Their 1H 
NMR spectra showed that the imidazoles of the histidine residues of had been oxidized 
to 2-oxo imidazoles, and also that Met 35 sulfur atom had been oxidized. It should be noted, 
however, that they did not investigate the kinetics of H2O2 production, i.e. did not compare 
the relative rates of H2O2 formation by Cu(II)/Ascorbate versus that of 
Cu(II)//Ascorbate. This group also states that reduction of Cu(II) to Cu(I) by occurs 
in the absence of ascorbate using an bathocuproinedisulfonic acid assay. This is contrary to 
the conclusions drawn from the reduction potential measurements of Jiang et al. (2007) as 
discussed above. Moreover, the XAS experiments by Streltsov et al. (2008) did not show any 
evidence for the reduction of Cu(II) by alone in the absence of any addition of a reducing 
agent. The effect on the binding of Cu(II) and the neurotoxicity of such oxidative 
modifications of is also of some interest.  
2.1 Cu(II) structural and modelling studies 
With the critical role Cu(II) plays in the properties of when it is bound to the peptide, 
considerable effort has gone into the structural determination of the Cu(II) binding site on 
. While there have been a number of reports of widely varying values for the binding 
affinity of Cu(II) for , one of the more reliable was the study by Hatcher et al. (2008). Their 
isothermal calorimetry (ITC) experiments for (1-40) at 37 C gave values of 1.1x109 M-1 and 
2.4x109 M-1 at pH 7.2 and pH 7.4, respectively. Under the same conditions (1-16) gave 
similar binding constants, indicating that the metal ion binding site is located in this N-
terminal fragment. The stoichiometry between Cu(II) and was 1:1. This is likely the 
binding at the higher affinity site since there are also several findings in the literature of 
binding more than 1 mole equivalent of Cu(II). For example, Caine et al. (2007) found 
that their maltose binding protein (MBP) – (1-42) fusion protein bound Cu(II) with a 
stoichiometry of 1:2. There has been some speculation as to the location of the second, 
weaker affinity binding site of Cu(II), (which is most likely an intermolecular site), but the 
major effort, as discussed below, has been on the high affinity binding site. 
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Streltsov et al. (2008) used a combined extended X-ray Absorption Fine Structure – Density 
Functional Theory (EXAFS-DFT) approach in their study of the Cu(II) binding site in (1-
16) where the experimental data was collected at 16.5 K with a metal:peptide ratio of 1:1 
buffered to a pH of 7.4. As the initial data analysis indicated a first shell coordination 
number of 6, they computed with Density Functional Theory (DFT) (at B3LYP/LANL2DZ 
level) two different optimized geometries with 3N3O coordination: in each case the nitrogen 
coordination was via three histidine imidazoles while the oxygen coordination was with a 
glutamate carboxylate (bidentate) and a water molecule in one case, and with a tyrosine 
hydroxyl oxygen and two water molecules in the other case. Using these two models in the 
EXAFS spectra fitting and refinement they found that the fit was significantly better with the 
octahedral Cu(II)/Glu/3His/Wat geometry, where the three histidine N atoms (at distances 
of 1.9-2.1 Å from the Cu ion) and one of the Glu carboxylate O atoms (1.9 Å distant from the 
Cu) are in approximately square planar equatorial arrangement while the other carboxylate 
O atom (2.3 Å distant from the Cu) and the water O (2.0 Å distant from the Cu) are in an 
axial arrangement. Figure 1 shows the arrangement of residues at the Cu(II) binding site 
for a molecular mechanics (MM) model developed for Cu(II)/(1-16) using the EXAFS 
determined coordination distances as constraints. (No constraints were applied to the 
peptide termini.) In analogy with the NMR solution structure for Zn(II)/(1-16) by Zirah 
et al. (2006) (discussed in Section 4), the glutamate is taken as Glu 11. Streltsov et al. also 
found that their fit could be further improved by placing two more oxygen atoms (assumed 
as coming from the Asp 1 carboxylate) 4.4 Å distant from the Cu(II) and hydrogen-bonded 
to the axially placed water. 
 
Fig. 1. Molecular model of Cu(II) bound to A(1-16) from EXAFS-DFT studies of Streltsov et 
al. (2008). 
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Numerous experiments in the past have shown the importance of the histidine residues of 
to copper binding. Smith et al. (2006) reported the loss of Cu/-induced toxicity when 
the histidine imidazole ǅ or ǆ N atom is methylated. They reported the observation of a 
histidine –bridged Cu(II)/dimer by EPR spectroscopy at Cu:peptide ratios greater than 
0.6:1. From the same laboratory, Smith et al. (2010) showed that the mutant H14A had no 
toxicity in primary neuronal cell cultures. Histidine-bridged Cu(II)/dimers were not 
seen in the EXAFS experiments of Streltsov et al.; however, as mentioned earlier this was at 
a Cu:peptide concentration ratio of 1:1. There is less evidence for the participation of Glu 11 
in the Cu(II) binding. It is interesting to note that the x-ray crystal structure of quercetin 2,3-
dioxygenase (Fusetti et al., 2002) contains a Cu(II) ion liganded by three histidines and a 
glutamate in a trigonal bipyramidal geometry. Furthermore, Hureau et al. (2011) very 
recently solved the x-ray crystal structure of Cu(II) bound to the peptide Gly-His-Lys, where 
Cu(II) displays a 3N1O coordination in the equatorial plane and a carboxylate O atom 
coordinating axially. Hence, the type of Cu(II) coordinating geometry proposed by Streltsov 
et al. has been seen in other contexts. However, the model would need to be validated by the 
results from EXAFS studies on mutants such as E11A. 
EXAFS and X-ray crystallography result in structures that are mostly static. However, there 
is ample evidence that the binding of metal ions to is a dynamical process, and is 
exquisitely sensitive to the experimental conditions such as pH and type of buffer. Drew et 
al. (2009a, 2009b) in a series of experiments involving continuous wave electron 
paramagnetic spectroscopy (CW-EPR) and hyperfine sublevel correlation spectroscopy 
(HYSCORE) showed that Cu(II) binding to is pleomorphic in nature. Using a number of 
15N labelled and 13C labelled (1-16) analogues, they found that the nature of the Cu(II) 
coordination shell was dependent on the pH. With these methodologies they conclude that 
at both pH 6.3 (“low pH”) and at pH 8.0 (“high pH”), the equatorial coordination of Cu(II) is 
3N1O. At low pH, two binding modes predominate (“component Ia” and “component Ib”): 
the imidazole N of His 6 and N-terminal Asp 1 NH2 and carbonyl O coordinate in both 
modes while the imidazole N of His 13 in one mode and the imidazole N of His 14 in the 
other mode constitute the fourth ligand. Drew et al. model (2009b) for the binding mode at 
high pH (“component II”) has the three histidine imidazole N atoms and the backbone 
carbonyl O atom of Ala 2 as the Cu(II) binding partners. They propose that this binding 
mode results in the polarization of the carbonyl C=O bond and facilitates the hydrolytic 
cleavage of the amide peptide bond between Ala 2 and Glu 3. This may be the possible 
source of (pyroglutamate 3-40 or 3-42) found in significant quantities in AD plaques. 
(Presumably glutaminyl cyclase in the brain cyclizes Glu 3 in the truncated N-terminal (3-
40 or 3-42).) Moreover, 13C, 15N, and 17O isotopic labelling provided no evidence of the 
involvement of the O atoms of the amino acid residues Glu 3, Asp 7, Glu 11 and Tyr 10. On 
the other hand, after performing both EPR and NMR experiments on isotopically labelled 
species, the Peter Faller group ( Dorlet et al. 2009, Eury et al. 2011) proposed that the 
equatorial coordination of component II consists of one histidine imidazole N, N-terminal 
Asp 1 NH2, Ala 2 carbonyl O, and finally the deprotonated Asp1-Ala2 peptide backbone 
amide N atom. They also proposed that the carboxylate O atom of Asp 1 binds in an axial 
position. However, it should be noted that EPR measurements are less sensitive to axially 
coordinating ligands and the interpretation of data is not straightforward (Sarell et al., 2009, 
Faller and Hureau, 2009).  
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Binding of Cu(II) to rat or murine is also of some interest as rats do not display amyloid 
plaque deposits (Shivers et al., 1998). Compared to the human peptide, the rat or mouse 
sequence contains the mutations R5G, H13R, and Y10F. Again using isotopically labelled 
EPR and NMR studies, Eury et al. (2011) propose that the component II binding mode of 
Cu(II)/murine (1-16) is characterized by hexa-coordination, with the 3N1O equatorial 
binding via His 6 imidazole N, N-terminal Asp 1 NH2 and carbonyl O, and the 
(deprotonated) Gly 5-His 6 backbone amidyl N atom. The axial ligands proposed are the His 
14 imidazole N atom and a carboxylate O atom from one of the acidic residues. 
Recently, Streltsov et al. (2011) solved the x-ray crystal structure of (18-41) within the 
framework of the CDR3 loop of shark IgNAR (Ig New Antigen Receptor) single variable 
domain antibody. The (18-41) portion of the structure that is observed in the crystal 
structure is tetrameric. By constructing oligomeric models with these tetramer units (see 
Figure 2), they noticed that the neighbouring tetramers align Glu 22 and Asp 23 on the same 
face and speculate that these acidic side chains, along with contributions from solvent 
exposed backbone N and O atoms, may constitute the second, weaker affinity 
intermolecular Cu(II) binding site. 
 
Fig. 2. Putative second binding site of Cu(II) from the (18-41) tetramer crystal structure of 
Streltsov et al. (2011) 
2.2 Cu(I) structural and modelling studies 
During the production of H2O2 by Copper/Abeta in the presence of a reducing agent, the 
oxidation state of copper continually cycles between the +2 and +1 states. Hence, the 
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structure of Cu(I) bound to is also of interest. XAS and EPR experiments by Shearer and 
Szalai (2008) on Cu(II)/(1-16) reduced with ascorbate showed the disappearance of the 
characteristic near-edge (XANES) spectral peaks of Cu(II) and the appearance of the peaks 
characteristic of Cu(I). The EXAFS data could be best fit with a linear imidazole-Cu(I)-
imidazole geometry with Cu-N distance of 1.9 Å. They hypothesize that these imidazoles 
belong to His 13 and His 14. Large basis set DFT calculations (B2-PLYP hybrid functional of 
Grimme, Ahlrichs’ def2-aug-TZVP basis for Cu and ligating N atoms, Ahlrichs’ TZVP basis 
set for other atoms) resulted in an optimized geometry with parameters similar to those 
measured by EXAFS. Figure 3 depicts their DFT-optimized geometry. In contrast, the XAS 
and NMR studies done by Hureau et al. (2009) indicate pleotropy in Cu(I) binding to  , 
showing that all three histidines contribute in a dynamical process. They propose a model 
where Cu(I) moves between binding to a histidine dyad (His 13 and His 14) and binding to a 
histidine triad (all three His). An alternative model would be an equilibrium between three 
histidine dyads: (His 13, His 14), (His 13, His 6), and (His 6, His 14). 
 
Fig. 3. Structural model of His 13 – Cu(I) – His 14 from DFT studies of Shearer & Szalai 
(2008), Reprinted from http://www.publish.csiro.au/nid/51/paper/CH09454.htm.  
2.3 Cu(II)/Cu(I) ROS chemistry modeling 
As mentioned above, quantum mechanical (QM) and molecular mechanical (MM) 
calculations have played important roles in the structural elucidation of Cu binding to . 
Structural models of DFT optimized geometries were an integral part of the EXAFS high-
affinity Cu(II) binding site determination by Streltsov et al. (2008).  
Computational chemistry, in particular ab initio QM calculations also have a major role to 
play in the elucidation of the mechanisms of ROS chemistry that occur as the result of Cu(II) 
binding to the N-terminus of . The laboratory of Rauk has carried out a number of ab 
initio computational studies of Cu binding to  and the resultant H2O2 production (Raffa et 
al., 2005; Raffa et al., 2007; Hewitt and Rauk, 2009). Hewitt and Rauk (2009) examined the 
mechanism of H2O2 generation by Cu(II)/ model system in the presence of an 
unspecified external reducing agent. The model system that they selected was two 
imidazoles linked by a peptide backbone, representing the His 13 – His 14 fragment of . 
The geometry optimizations were done with DFT calculations at B3LYP/6-31+G(d) level 
while enthalpy calculations were done with single point energy calculations at B3LYP/6-
311+(2df, 2p) level. The reaction pathway or redox cycle computed in this study is depicted 
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schematically in Figure 4. In the first step, the most stable (according to their calculations) 
Cu(II) species is reduced to the most stable Cu(I) species. The former species has 2N2O 
coordination, with the N ligands being His 13 and His 14 imidazole N atoms while the O 
ligands are the backbone carbonyl O and a water molecule. The most stable Cu(I) species 
has a linear geometry, with the Cu(I) coordinated by His 13 and His 14 imidazole N atoms.  
 
Fig. 4. Simplified reaction scheme of Hewitt and Rauk for the generation of H2O2 by 
Cu(II)/A. Adapted with permission from Hewitt and Rauk (2009). Copyright (2009) 
American Chemical Society. 
In the next step, this Cu(I) species forms a loose adduct with molecular O2 (in its triplet spin 
state). This species then takes part in a proton coupled electron transfer (PCET) reaction due 
to the participation by some external reducing agent (such as ascorbate or glutathione). In 
the final step, protonation followed by associative substitution by a water molecule leads to 
the production of H2O2 and the regeneration of the original Cu(II) species. Among their 
findings is that the generation of superoxide to be energetically unfavourable, consistent 
with the non-observation of superoxide by Huang et al. (1999b) during the Cu(II)/ 
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generation of H2O2. However, their starting structural model for Cu(II)/, i.e. 2N2O 
coordination, is at variance with most experimental studies on the Cu(II) binding site as 
discussed in the previous section. Hewitt and Rauk state that at the level of theory that they 
employed, axial ligands to Cu(II) dissociate in water. They computed a reduction potential 
of 0.52 V (vs. the NHE) for the first step. This is significantly higher than the value of 0.28 V 
measured by Jiang et al. (2007) for Cu(II)/Cu(I) couple when bound to . 
A few years previous to the work of Hewitt and Rauk, Barnham et al. (2004) also used ab 
initio DFT calculations to propose a reaction mechanism for the production of H2O2 by 
Cu(II)/ in the presence of (excess of) ascorbate. Their computation (at the 
B3LYP/LANL2DZ level) starts the redox cycle with Cu(II) coordinated by three histidines 
and tyrosine. Cu(II) is reduced to Cu(I) by ascorbate in a PCET step, dissociating the 
tyrosine. Molecular O2 coordinates the Cu(I) and oxidizes it back to Cu(II). Hydrogen atom 
transfer from the tyrosine and simultaneous abstraction of a proton from the medium leads 
to the formation of H2O2 and a tyrosyl radical. Tyrosyl radicals from  molecules close to 
each other can then lead to the formation of experimentally observed dityrosine-linked  
dimer. The presence of transient radicals was shown by the use of the radical trapping agent 
2-methyl-2-nitrosopropane. Such radicals were absent in the case of the  mutant Y10A, 
which was also not toxic in neuronal cell assays. On the other hand, subsequent structural 
work on the Cu(II) binding site (discussed above) have now ruled out the participation of 
tyrosine 10 in the binding of Cu(II). Furthermore, Barnham et al. (2004) also reported that 
the Y10A mutant still produced H2O2, albeit at half the rate of wild-type . Obviously, 
other mechanisms, not involving binding of Tyr 10 to Cu(II), can lead to the generation of 
H2O2 by Cu(II)/ in the presence of ascorbate. 
It is by now quite apparent that Cu binding to  is a pleotropic, dynamical phenomenon, 
although at a given set of conditions such as pH and buffer a particular species may 
predominate over others. Molecular dynamics (MD) calculations would be the preferred 
computational tool to investigate such dynamical processes. Classical MD employing 
empirical force fields cannot deal with breaking and formation of bonds, so techniques such 
as CPMD and QM/MM-MD are advantageous in this regard. Furlan et al. (2010) have used 
ab initio (or Car-Parrinello) molecular dynamics (CPMD) calculations to investigate the Cu(I) 
binding to . Starting from a number of different Cu(I)/ geometries (employing either 
two histidine or three histidine topologies), the simulations of Furlan et al. showed that a 
linear His 13 – Cu(I) – His 14 arrangement was the most stable, although certain interactions 
between the peptide and the metal ion may lead to the approach and binding of His 6. It 
must be noted that because of the highly compute-intensive nature of CPMD, their 
simulation was quite short at 1 ps. It is known that the linear imidazole-Cu(I)-imidazole 
geometry is particularly stable (Le Clainche et al., 2000), and it is interesting to speculate 
whether a transient formation of a triply coordinated Cu(I) species might be necessary for its 
reactivity towards molecular dioxygen. 
Concurrent with the studies described above on elucidating the nature of Cu interaction 
with  and the effects on toxicity, there have been work designing novel chemical entities 
to ablate the neurotoxicity by interfering with the Cu binding to . As mentioned in the 
introduction, successful results of phase IIa clinical trials of a copper ligand PBT2 have been 
announced (Adlard et al., 2008; Lannfelt et al., 2008). This compound is the second-
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generation version of another copper ligand, Clioquinol (Figure 5). These two compounds 
were shown to be capable of significantly reducing the amount of  aggregation, H2O2 
generation, and dityrosine-linked  production. They significantly improved the level of 
cognition in AD patients. Adlard et al. (2008) hypothesized that these compounds act more 
as ionophores, i.e. removing the copper bound to  and transporting it inside the neuronal 
cells, leading to upregulation of matrix metalloproteases and subsequently to the 
degradation of . 
 
Fig. 5. Chemical structure of Clioquinol 
3. Iron and amyloid beta 
Iron, like copper, is a redox-active metal and plays a critical role in the human body, being 
an essential component of haemoglobin and a number of enzymes. After the liver, the organ 
with the richest concentration of iron is the brain, normally containing in the order of 60 mg 
of non-haeme iron in the adult brain (Duce & Bush, 2010). However, being redox-active, it is 
also capable of participating in Fenton and Haber-Weiss type reactions and generating 
hydroxyl radicals, superoxide, and other reactive oxygen species, and is a potential source 
of oxidative stress in the brain. The Fe(III)/Fe(II) system has a standard reduction potential 
of 0.77 V, i.e. greater than that of the Cu(II)/Cu(I) system. Maintaining strict homeostasis of 
the iron levels and the oxidation state it is in is essential for maintaining the health of the 
body. This occurs in the healthy body with the activities of ferroxidases such as 
ceruloplasmin, iron transport proteins like transferrin, and iron strorage proteins such as 
ferritin. Recently, Duce et al. (2010) proposed that the amyloid precursor protein, APP, also 
has ferroxidase activity, converting Fe(II) to Fe(III). They found this function was located in 
the E2 domain (residues 365-495) of APP, associated with the motif REXXE, and to be 
inhibited by Zn(II). With normal ageing, the iron content in the brain has been found to 
increase. Iron also has been found to be concentrated in senile plaques of AD brains. Lovell 
et al. (1998) found AD neuropils to contain more than twice the amount of iron found in 
control neuropils. 
Despite this importance of iron, there has not been much published work on the interaction 
of iron with amyloid beta. Liu et al. (2010) have proposed that iron promoted the toxicity of 
by actually delaying the formation of well-ordered aggregates of such as the fibrils 
found in AD. The easy oxidation of Fe(II) to Fe(III) and the hydrolysis and precipitation of 
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Fe(III) at physiological pH are some of the reasons hindering experimental studies. To get 
around the latter problem, Jiang et al. (2009) used the complex between Fe(III) and 
nitrilotriacetic acid (NTA) in their work on the interaction with and redox properties. 
They found that Fe(III)-NTA bound to extremely strongly, with a measured dissociation 
constant of 6.3x10-21 M. In comparison, that for Fe(II)-NTA was 5.0x10-12 M. Furthermore, 
using cyclic voltametry they determined that the redox potential for Fe(II)-NTA to be 0.23 V 
when complexed to .  
Just as in the case of Cu(II), there have been contradictory reports on the amino acid 
residues of involved in coordinating Fe. An early Raman spectroscopic study by Miura 
et al. (2001) concluded that while Tyr 10 was central to the binding of Fe(III), the three 
histidines in the N-terminal region were not involved. On the other hand, Nakamura et 
al. (2007) in their study of the redox activity of Cu and Fe in association with , conclude 
that, just like for Cu, the three histidines are necessary of the binding of Fe. Most recently, 
the group of Faller and Hureau used NMR, including 1H, 13C, and 2D studies in an attempt 
to determine the coordination shell of Fe(II) in binding to (Bousejra-El Garah et al., 2011). 
Analyzing the line broadening in the NMR spectra induced by Fe(II) binding to (1-16), 
(1-28), and (1-4) peptides, they concluded that firstly, neither Tyr 10 nor Met 35 had 
any role in Fe(II) coordination. Secondly, they identified Asp 1, Glu 3, His 6, His 13, and His 
14 as the residues involved in binding Fe(II). Assuming hexa-coordination of Fe(II), they 
propose a 3N3O first coordination shell for Fe(II). i.e. The equatorial ligands are the 
imidazoles of His 6 and His 13 or His 14 as well as the N-terminus of Asp1 and the 
backbone carbonyl oxygen from Asp1 or His 6. The axial ligands consist of the carboxylate 
oxygens of Asp 1 and Glu 3. This is schematically depicted in Figure 6. More precise 
determination of the 3D structure of the binding site awaits future work. No EXAFS studies 
on Fe binding to have been reported yet. Notably, Bousejra-El Garah et al. did not find 
any pH dependence for the Fe(II) binding to near physiological pH. 
 
Fig. 6. Model for Fe(II)/A coordination by Bousejra-El Garah et al. (2011). Adapted with 
permission from Bousejrah-El Garah et al. (2011). Copyright (2011) American Chemical 
Society. 
Also very recent is an abinitio study by Rauk and co-workers on the structures and 
stabilities of Fe(II) and Fe(III) complexes with fragments (Ali-Torres et al., 2011). Their 
calculations consisted of single point energies calculated at MP2 level with a large 6-
311+G(2df,2p) basis set at geometries optimized with the DFT functional B3LYP with a 
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small 6-31G(d) basis set. Solvent effects were included with an IEFPCM (polarisable 
continuum model with the integral equation formalism variant). They determined that the 
most stable complexes containing His-His (i.e. His 13 – His 14) and phenolate (derived from 
Tyr 10) are the two penta-coordinated species [Fe(II)(O-HisHis)(PhO-)(H2O)]+ and [Fe(III)(N-
HisHis)(PhO-)(H2O)]+. These structures are shown in Figure 7. They concluded that the 
simultaneous coordination of Tyr10 and His 13 - His 14 to Fe(II) and to Fe(III) is 
thermodynamically favourable. However, as we saw from the NMR results by Bousejra-
ElGarah et al., it is unlikely that utilizes Tyr 10 in coordination to Fe(II). Ali-Torres et al. 
computing the standard reduction potentials, determined that this coordination by Tyr and 
His-His reduces Fe(III)/Fe(II) reduction by about 0.5 V (compared to aqueous Fe(III)/Fe(II)) 
to 0.20 V. We note that this value is quite close to the value of 0.23 V experimentally 
determined by Jiang et al. (2009) for the Fe(III)-NTA system complexed to . 
  
Fig. 7. The most stable Fe(II) (left) and Fe(III) (right) structural models by Ali Torres et al. 
(2011). Reprinted with permission from Ali Torres et al. (2011). Copyright (2011) American 
Chemical Society. 
Finally, it should be mentioned that some Fe(III) chelating compounds have been tested as 
possible therapeutics for AD. Two such compounds are desferrioxamine and deferiprone 
(Figure 8). While they are used as iron chelators to treat iron overload conditions, their 
efficacy as AD therapeutics is doubtful, and they also bind other metal ions such as Cu(II) 
and Zn(II). 
   
Fig. 8. Chemical structures of desferrioxamine (left) and deferiprone (right) 
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4. Zinc and amyloid beta 
Zinc, like Copper, is known to play a major role in Alzheimer’s Disease pathogenesis. 
However, unlike copper (and iron), zinc, normally found only in the Zn(II) state, is not 
redox-active. While Zn is an essential component in a number of enzymes, its role is 
probably mostly structural rather than reactive chemically. The brain is a rich source of 
Zn(II). During neuronal activity, the concentration of Zn(II) released into the synaptic cleft 
can be as high as 1mM (Duce & Bush, 2010). The zinc transporter ZnT3 activity is key during 
this process. With age, hippocampal Zn as well as ZnT3 levels have been found to decrease 
(Adlard, 2010). Zn(II) binding to facilitates the amyloid aggregation. AD brain plaques 
are highly enriched in zinc, reaching millimolar concentrations (Lovell, 1998). The metal 
ionophores, Clioquinol and PBT2, discussed earlier, show moderate binding of Zn(II), and 
Adlard et al. (2008) observed the dissolution of Zn-induced (1-42) aggregates upon 
treatment with these compounds. Faller and Hureau (2009) concluded that Zn(II) had a 
binding affinity to of 1-20 μM, which is weaker than that shown by Cu(II). However, this 
value is highly dependent on the assay conditions and probably on the aggregation state of 
.  
The structure of the Zn(II) binding site in has been the subject of a number of studies. 
While most experiments appear to agree that the triad of histidines, His 6, His 13, and His 14 
coordinate the Zn(II) ion, there is some disagreement on the identity of the fourth 
coordinating amino acid residue. In 2006, Zirah et al. (2006) determined the solution 
structure of Zn(II) bound to (1-16) in aqueous solution at pH 6.5 using 1H and 13 C 1- and 
2-dimensional NMR experiments. Here, Zn(II) displays a flattened tetrahedral geometry 
with the Nǅ atoms of His 6 and His 14, and the Nǆ atom of His 13 at the ‘base’ and the 
carboxylate O atoms of the bidentate Glu 11 at the apex. Notably, the two O atoms of Glu 11 
are equidistant from the Zn at 2.1 Å. His 6 and His 13 are also 2.1 Å distant from the metal 
while His 14 is at 2.3 Å. It is noteworthy that the peptide used in these studies was N-
acetylated at the N-terminus, thus hindering any potential involvement of Asp 1 in the Zn 
coordination. The geometry of the Zn(II) binding site is depicted below in Figure 9 (PDB id: 
1ZE9). 
When the N-terminal of is not acetylated, NMR studies point to the involvement of Asp 
1 in the coordination of Zinc. For example, using high resolution NMR 1H-13C and 1H-15N 
heterocorrelation experiments on (1-40), Danielsson et al. (2007) propose that the three 
histidines and most likely the N-terminal NH2 of Asp 1 coordinate Zn(II). However, they do 
not rule out the possibility of the carboxylate oxygen atom of Asp 1 as a Zn(II) ligand. On 
the other hand, Minicozzi et al. (2008) observed that at pH 7, the EXAFS spectrum of (5-
23) looked very similar to those of (1-16), (1-28), and (1-40). They determine that the 
best fit to the data is with 4 histidines and a oxygen atom, and hence conclude that what 
they observe is best explained by Zn(II) cross-linking 2 chains, each chain contributing 2 
histidines to the first coordination shell. Finally, comparative 1H NMR studies on human 
and rat (1-28) in water/sodium dodecyl sulphate (SDS) micelles were carried out at pH 
7.5 by Gaggelli et al. (2008). The chemical shift variations and line broadening led them to a 
penta-coordinated structural model for Zn(II)/(1-28) where the Zn(II) is liganded by Asp 
1 (N-terminal NH2 group), His 6, His 13, His 14, and the carboxylate oxygen atom of Glu 11. 
The last ligand was strongly evidenced by the down field 1H chemical shifts for Glu 11 upon 
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the addition of Zn(II). Notably, large downfield shifts were also observed for Tyr 10, which 
were ascribed to conformational changes brought about by Zn(II) binding rather than direct 
involvement of Tyrosine as a ligand. They also determined the Zn(II) coordination shell 
when bound to the rat (1-28). The rat differs from the human peptide in three 
important mutations: Arg 5 → Gly, Tyr 10 → Phe, and His 13 → Arg. Their structural model 
for Zn(II) with rat (1-28) has the metal ion tetrahedrally coordinated with the ligands Asp 
1 NH2 group, His 6 and His 14 imidazoles, and Glu 11 carboxylate. Thus there is very little 
change in the mode of binding in going from the human to rat sequence, resulting only in 
the loss of His 13 as a ligand. 
 
Fig. 9. Zn(II)/A(1-16) NMR solution structure of Zirah et al. (2006). 
The minimal Zn(II) binding fragment of has been the subject of QM/MM (hybrid quantum 
mechanics / molecular mechanics) simulations and ITC (isothermal calorimetry) experiments 
(Tsvetkov et al., 2010). The QM/MM calculations (performed combining the Car-Parinello 
molecular dynamics code CPMD with the MM package GROMACS) used the NMR solution 
structure of Zirah et al. (2006) as the initial geometry and included the metal ion and the side-
chains of His6, His 13, His 14 and Glu 11 in the QM region. These calculations (run for a 
maximum of 8 ps) on Zn(II) complexed to (1-16) and (6-14) showed stable structures 
when Zn(II) was liganded by the three histidines and Glu 11. ITC on different sized 
fragments as well as H6R and E11A mutants of (1-16) at pH 7.3 all indicated that (6-14) 
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contained the minimal binding region of . They proposed Zn(II) is first coordinated by 
E11VH13H14, followed by His 6 binding. Ab initio molecular dynamics was also the 
computational methodology of choice used by Furlan and La Penna (2009) to investigate the 
stability of Zn(II) binding by different (1-16) residues (this time using an implementation of 
CPMD in the Quantum Espresso package). Simulations in vacuo at 300 K of 1-2 ps length 
supported the structural model of coordination by the three histidines and Glu 11. On the 
other hand, involvement of Asp1 in the binding resulted in the expulsion of a histidine from 
the coordination shell. Finally, Tyr 10 liganding the metal ion in competition with Glu 11 or 
Asp1 appeared to be possible only when the tyrosine is first deprotonated. It should also be 
noted that in these theoretical models discussed above, Glu 11 displays monodentate, not 
bidentate binding to Zn(II). Miller et al. (2010) performed replica exchange molecular 
dynamics simulations with Zn(II)/ models found that the zinc ions can simultaneously 
coordinate  both intramolecularly as well as intermolecularly, and hence facilitate  
aggregation. Their simulations, commenced from structural models constructed using the 
Zirah et al. Zn(II)/(1-16) structure discussed above and the (17-42) fibril structure of 
Luhrs et al. (2005), ran for 20 ns. They observed that the Zn(II) coordination decreased the 
solvation energy of Zn(II)/ oligomers, again facilitating the amyloid aggregation. 
Finally, it is also interesting that the high resolution NMR studies by Danielsson et al. (2007) 
also appeared to suggest the presence of a second, weaker, Zn(II) binding site in the central 
region of , involving residues 23, 24, 26, and 28. The putative second Cu(II) binding site 
mentioned in section 2.1, suggested by the p3-IgNAR tetrameric crystal structure of Strelsov 
et al. (2011) has the potential also to be a second Zn(II) binding site. Confirmation of this as a 
second Zn(II) binding site awaits future experiments. 
5. Platinum, Ruthenium, Rhodium, and Iridium metals and amyloid beta 
While the major body of work of on the interactions of metals with Amyloid beta () has 
been of those metals with biological significance and found in the brain, i.e. Cu, Zn, and Fe, 
more recently there has been interest in the study of the interaction of with 
organometallic compounds involving transition metals Platinum (Pt), Ruthenium (Ru), 
Rhodium (Rh), and Iridium (Ir). While there is no evidence that the interaction of these 
metals with is of any biological significance, and indeed that such interactions occur at 
all in the human brain, they do have significance as prototypes or templates for potential 
therapeutics in order to ablate the neurotoxicity induced by . 
The first study in this area was that by Barnham et al. (2008) on the effects of binding of 
to Cisplatin and Cisplatin-derived compounds. The Pt compounds involved in this study 
were cisplatin, Pt(1,10-phenanthroline)Cl2, Pt(4,7-diphenyl-[1,10]-phenanthroline)Cl2 and 
Pt(4,7-diphenyl-[1,10]-phenanthroline disulfonate)Cl2, (i.e. compounds 1, 2, 3, and 4 in this 
study), and are depicted in Figure 10. The impetus behind this work was the knowledge that 
the N-terminal residues, and in particular the histidines at positions 6-, 13-, and 14- were 
important in the toxicity induced by (Atwood et al., 2000), and that aromatic compounds 
appeared to bind to and, at the least, affect its fibril forming tendency. In particular, 1,10-
phenanthroline compounds (in the absence of any metals) appear to have a weak affinity to 
the N-terminal residues Phe 4, Tyr 10, and Phe 19 (Yao et al., 2004). The three histidines, His 
6, His 13, and His 14, of course, are included in this segment of .  
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Fig. 10. Platinum compounds used for binding to A by Burnham et al. (2008) 
Barnham et al. found that while all four compounds bound to (1-40), only compounds 2, 
3, and 4, and not 1, (i.e. cisplatin), had significant effects on the behaviour of the peptide. 
Compounds 2, 3, 4 inhibited the aggregation of (1-40), with EM showing the absence of 
fibrils. They significantly inhibited the Cu(II) induced generation of H2O2, with the 
measured IC50 values in the nanomolar range. This is comparable to the inhibition of ROS 
generation by clioquinol as discussed earlier. Furthermore, these compounds significantly 
inhibited the induced neurotoxicity, increasing the cell viability of primary mouse 
cortical neurons in cell cultures. Finally, they rescued the induced inhibition of long-term 
potentiation (LTP) in mouse hippocampal slices. How do these compounds have such 
beneficial effects on biological properties while cisplatin does not? The 1H NMR 
experiments of Barnham et al. appear to show that while compounds 2-4 bind the N-
terminal histidines of , cisplatin binds the C-terminal Met 35. At a first glance, this 
appears to explain why compounds 2-4 and not cisplatin inhibits H2O2 generation. (And 
incidentally, is further confirmation that Met 35 is not involved in the ROS generating 
activity of .) However, determination of all the coordinating residues of has not been 
done, and more extensive and definitive structural studies on the complexes of with 
these Pt compounds are necessary. Such studies, both experimental as well as 
computational, are now underway at our laboratory (CSIRO). These would, hopefully, 
provide complete 3-dimensional structural models of the -Pt compound complexes. Such 
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structures would not only explain the differences in the chemical properties of the different 
compound complexes, but also be templates or leads for the development of effective 
therapeutics for AD. Among the qualities effective neuroprotective agents should have are 
good blood-brain barrier crossing properties. It should be noted that cisplatin has been used 
for some time as a cytotoxic drug in anti-cancer therapy. However, Barnham et al. did not 
notice toxicity to cells of these Pt compounds at the concentrations that were used in their 
experiments, i.e. 5 μM and 10 μM. 
Following this work, Valensin et al. (2009) published their study of the interaction of A(1-
28) with the Ruthenium compound fac-[Ru(CO)3Cl2-N1-1,3-thiazole] (where Ru has a +2 
charge). Given the fact that Ru compounds are in general far less cytotoxic than Pt 
compounds, and the fact that Ru compounds prefer coordination to imidazole nitrogen 
atoms, they strongly suggest Ru compounds such as theirs be considered as potential 
therapeutics for Alzheimer’s Disease. The 1H NMR experiments they carried out appear to 
indicate that the chlorines in the compound are substituted by the histidine imidazoles of 
the peptide. In addition to the histidines, Tyr 10 also appears to be implicated. 
Supporting their conclusions, rat (1-28) (which differs in the mutations R5G, Y10F, and 
H13R) was significantly less affected by the Ru compound. Once again, definitive structural 
determinations remain to be done. The circular dichroism experiment carried out by 
Valensin showed that the peptide underwent conformational changes upon binding to the 
Ru compound. However, they did not perform any peptide aggregation, ROS generation, 
cell viability, or LTP studies with their compound. 
More recently, Man et al. (2011) have investigated the use of Group 9 transition metal 
Rhodium (Rh(III)) and Iridium (Ir(III)) compounds to inhibit aggregation via these 
metals’ coordination to the N-terminal histidines. Their Rh and Ir solvato-complexes contain 
2-phenyl pyridine, benzoquinoline, or phenyl quinoline ligands. Presumably, the labile 
solvent (H2O) molecules are displaced by the histidine imidazoles upon binding to . Man 
et al. found that the Rh(III) compound with phenyl pyridine as ligand was the most effective 
in the inhibition of fibril formation by (1-40).  
6. Conclusion 
Diverse experimental techniques have been utilized over the past few years in elucidating 
the nature of the interactions of transition metal ions with the amyloid beta peptide. Much 
of it has concerned copper, in both its oxidation states, due to its redox activity and 
biological relevance. It is clear that the interactions are complex, and very sensitive to 
ambient conditions. This makes it quite challenging to discern the interactions that are 
occurring in the brain. As of yet there is no x-ray crystallographic structure of a metal ion 
complexed with . The pleotropic nature of the binding as well as the lack of definite 
(secondary) structure in the N-terminal region of  makes obtaining such a crystal 
structure an arduous task. On the other hand, crystal structures of metal ions with  as 
suitable fusion protein constructs or within stable protein scaffolds or ternary complexes 
with  and antibody fragments are worthy goals. Also of great interest would be the 
structural determination of complexes of any of the organometallic compounds with . 
Such structures could provide templates for the design of therapeutics and diagnostics for 
AD. Computational studies, particularly when done in conjunction with experiments, also 
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have contributed considerably to our current understanding of metal interaction with . 
Ab initio MD and hybrid QM/MM-MD methodologies hold great promise in providing 
insight into the dynamical processes and the ROS chemistry resulting from the metal-
peptide interactions. In performing these simulations carrying them out in biologically 
relevant time scales will be a challenge that will need to be met. It will also be of use to tie in 
the calculations as close as possible to the experiments, for example commencing 
simulations from reliable and relevant experimental structural models. Finally, we note that 
two fundamental questions in the study of the aetiology of AD are yet to be answered 
satisfactorily: what is the toxic species and what is the mechanism of toxicity. 
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